文献速递慢性肾脏病肾小球疾病肾移植

APOL1基因变异是非裔HIV感染者肾衰竭的主要决定因素

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV.
PubMed 文献 · Kidney Int Rep · 2022-01-25

在英国开展的一项横断面研究纳入2864名非裔HIV感染者,其中12.4%携带APOL1高危基因型,3.5%发生终末期肾病。校正人口学、HIV及肾脏危险因素后,APOL1高危基因型与终末期肾病、肾功能受损、白蛋白尿及HIV相关肾病均呈强关联,估计49%的终末期肾病可归因于APOL1高危基因型。

要点

  • 非裔HIV感染者中APOL1高危基因型占12.4%,与终末期肾病强关联(OR 10.58)。
  • APOL1高危基因型与HIV相关肾病关联最强(OR 30.16)。
  • 估计49%的终末期肾病可归因于APOL1高危基因型。

核心结论

  • APOL1高危基因型与非裔HIV感染者的肾脏疾病强关联,并解释了该队列中约一半的终末期肾病病例。

研究设计与样本

  • 横断面研究,在英国纳入2864名非裔HIV感染者,平均年龄48.1岁(标准差10.3),女性占57.3%。
  • 主要结局为终末期肾病(eGFR<15 ml/min per 1.73 m2、慢性透析或已接受肾移植),次要结局包括肾功能受损(eGFR<60 ml/min per 1.73 m2)、白蛋白尿(ACR>30 mg/mmol)和活检证实的HIV相关肾病。
  • 采用多变量logistic回归估计APOL1高危基因型(G1/G1、G1/G2、G2/G2)与肾脏疾病结局的关联。

主要发现

  • 2864名参与者中354名(12.4%)携带APOL1高危基因型,99名(3.5%)发生终末期肾病。
  • 校正人口学、HIV及肾脏危险因素后,APOL1高危基因型与终末期肾病风险升高相关(OR 10.58,95%CI 6.22-17.99)。
  • APOL1高危基因型与肾功能受损(OR 5.50,95%CI 3.81-7.95)、白蛋白尿(OR 3.34,95%CI 2.00-5.56)及HIV相关肾病(OR 30.16,95%CI 12.48-72.88)风险升高相关。
  • 估计49%的终末期肾病可归因于APOL1高危基因型。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Variants of the APOL1 gene are associated with chronic kidney disease (CKD) in people of African ancestry, although evidence for their impact in people with HIV are sparse. METHODS: We conducted a cross-sectional study investigating the association between APOL1 renal risk alleles and kidney disease in people of African ancestry with HIV in the UK. The primary outcome was end-stage kidney disease (ESKD; estimated glomerular filtration rate [eGFR] of <15 ml/min per 1.73 m2, chronic dialysis, or having received a kidney transplant). The secondary outcomes included renal impairment (eGFR <60 ml/min per 1.73 m2), albuminuria (albumin-to-creatinine ratio [ACR] >30 mg/mmol), and biopsy-proven HIV-associated nephropathy (HIVAN). Multivariable logistic regression was used to estimate the associations between APOL1 high-risk genotypes (G1/G1, G1/G2, G2/G2) and kidney disease outcomes. RESULTS: A total of 2864 participants (mean age 48.1 [SD 10.3], 57.3% female) were genotyped, of whom, 354 (12.4%) had APOL1 high-risk genotypes, and 99 (3.5%) had ESKD. After adjusting for demographic, HIV, and renal risk factors, individuals with APOL1 high-risk genotypes were at increased odds of ESKD (odds ratio [OR] 10.58, 95% CI 6.22-17.99), renal impairment (OR 5.50, 95% CI 3.81-7.95), albuminuria (OR 3.34, 95% CI 2.00-5.56), and HIVAN (OR 30.16, 95% CI 12.48-72.88). An estimated 49% of ESKD was attributable to APOL1 high-risk genotypes. CONCLUSION: APOL1 high-risk genotypes were strongly associated with kidney disease in people of African ancestry with HIV and accounted for approximately half of ESKD cases in this cohort.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Hung RKY, Binns-Roemer E, Booth JW, et al. Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV. Kidney Int Rep. 2022. PMID: 35497797. doi:10.1016/j.ekir.2022.01.1054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。